Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Japanese Subjects With Moderate-To-Severe Plaque-Type Psoriasis
NCT01988103Phase 2Completed
- Sponsor
- Amgen
- Start
- Jul 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in plaque psoriasis, sponsored by Amgen. Started Jul 2013; status: completed.
02
Drugs
apremilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01988103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01988103.